Biobytes Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Biobytes General Information

Description

Developer of an AI-based platform designed to assess sarcopenia risk and support biomarker discovery for muscle health. The company's platform offers large-scale clinical and molecular data analysis capabilities, enabling healthcare providers and research organizations to identify muscle health indicators and informed approaches to managing age-related muscle decline.

Contact Information

Website
www.biobytes.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 211-2, Industry-Academic-Research Cooperation Complex
  • Jiphyeon Hall, Foundation for Industry-Academic Cooperation, 1 Gangwondaehak-gil, Hyoja-do
  • Chuncheon, Gangwon 24341
  • South Korea
+82
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Vertical(s)
Digital Health, Wearables & Quantified Self, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Room 211-2, Industry-Academic-Research Cooperation Complex
  • Jiphyeon Hall, Foundation for Industry-Academic Cooperation, 1 Gangwondaehak-gil, Hyoja-do
  • Chuncheon, Gangwon 24341
  • South Korea
+82

Biobytes Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biobytes Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 06-Aug-2026 Completed Generating Revenue
5. Early Stage VC 04-Jun-2026 Completed Generating Revenue
4. Accelerator/Incubator 20-Jun-2025 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Seed Round 12-Nov-2024 $500K $500K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Biobytes’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Biobytes Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an AI-based platform designed to assess sarcopenia risk and support biomarker discovery for muscle health.
Other Healthcare Technology Systems
Chuncheon, South Korea
12 As of 2026

Chicago, IL
 

Marlborough, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biobytes Competitors (3)

One of Biobytes’s 3 competitors is GE HealthCare Technologies, a Corporation company based in Chicago, IL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GE HealthCare Technologies Corporation Chicago, IL
Hologic Private Equity-Backed Marlborough, MA
InBody Corporation Seoul, South Korea
You’re viewing 3 of 3 competitors. Get the full list »

Biobytes Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Biobytes Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026197812-A1 Composition for preventing, alleviating or treating sarcopenia, comprising leucine and turmeric extract as active ingredients Pending 19-Mar-2025
WO-2025258904-A1 Method and apparatus for predicting sarcopenia Pending 13-Jun-2024

Biobytes Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biobytes Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Behigh Investment Venture Capital Minority
Korea Technology Finance Government Minority
Tech Incubator Program for Startup Accelerator/Incubator
Center for Creative Economy and Innovation Accelerator/Incubator Minority
CNT Tech Accelerator/Incubator Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Biobytes FAQs

  • When was Biobytes founded?

    Biobytes was founded in 2023.

  • Where is Biobytes headquartered?

    Biobytes is headquartered in Chuncheon, South Korea.

  • What is the size of Biobytes?

    Biobytes has 12 total employees.

  • What industry is Biobytes in?

    Biobytes’s primary industry is Other Healthcare Technology Systems.

  • Is Biobytes a private or public company?

    Biobytes is a Private company.

  • What is Biobytes’s current revenue?

    The current revenue for Biobytes is .

  • How much funding has Biobytes raised over time?

    Biobytes has raised $1.9M.

  • Who are Biobytes’s investors?

    Behigh Investment, Korea Technology Finance, Tech Incubator Program for Startup, Center for Creative Economy and Innovation, and CNT Tech are 5 of 9 investors who have invested in Biobytes.

  • Who are Biobytes’s competitors?

    GE HealthCare Technologies, Hologic, and InBody are competitors of Biobytes.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process